Validation of a serological ELISA method to detect anti-SarsCov2 IgG and IgM antibodies in Mexican population

Authors

• Mabel Rodriguez, Instituto de Biotecnología, MexicoFollow
• Luis Fernando Losoya, LAMMB, Instituto de Biotecnología UNAM
• Luis Eduardo Hernandez, LAMMB, Instituto de Biotecnología UNAM
• Arlene Calderón, LAMMB, Instituto de Biotecnología UNAM
• Maricela Olvera, LAMMB, Instituto de Biotecnología UNAM
• Juan Carlos Rivera, LAMMB, Instituto de Biotecnología UNAM
• Miguel Mendoza, LAMMB, Instituto de Biotecnología UNAM
• Laura Alicia Palomares, LAMMB, Instituto de Biotecnología UNAM
• Octavio Tonatiuh Ramírez, LAMMB, Instituto de Biotecnología UNAM
• Daniel Barreto, LAMMB, Instituto de Biotecnología UNAM

Conference Dates

May 19 - 24, 2024

Abstract

Please click Additional Files below to see the full abstract.

Recommended Citation

Mabel Rodriguez, Luis Fernando Losoya, Luis Eduardo Hernandez, Arlene Calderón, Maricela Olvera, Juan Carlos Rivera, Miguel Mendoza, Laura Alicia Palomares, Octavio Tonatiuh Ramírez, and Daniel Barreto, "Validation of a serological ELISA method to detect anti-SarsCov2 IgG and IgM antibodies in Mexican population" in "Vaccine Technology IX", Linda Lua, The University of Queensland, Australia; Charles Lutsch, Sanofi-Vaccines, France; Francesc Gòdia, Universitat Autònoma de Barcelona (UAB), Spain; Tara Tagmyer, CMC Leader, USA Eds, ECI Symposium Series, (2024). https://dc.engconfintl.org/vaccine_ix/35